PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30540190-7	2019	Catalysis of methionine oxidation within the N-terminal domain of the huntingtin protein may potentially provide a strategy for delaying the onset of Huntington"s disease.	Methionine	13-23	huntingtin	Homo sapiens	70-80	
22891249-4	2012	Here we focus upon aggregation of huntingtin (HTT), which causes a neurodegenerative disorder, Huntington disease, and we show that oxidation of a methionine residue in HTT occurs in vitro and also in vivo.	Methionine	147-157	huntingtin	Homo sapiens	34-44	
22891249-4	2012	Here we focus upon aggregation of huntingtin (HTT), which causes a neurodegenerative disorder, Huntington disease, and we show that oxidation of a methionine residue in HTT occurs in vitro and also in vivo.	Methionine	147-157	huntingtin	Homo sapiens	46-49	
22891249-4	2012	Here we focus upon aggregation of huntingtin (HTT), which causes a neurodegenerative disorder, Huntington disease, and we show that oxidation of a methionine residue in HTT occurs in vitro and also in vivo.	Methionine	147-157	huntingtin	Homo sapiens	169-172	
22891249-5	2012	Copper ions as well as added hydrogen peroxide are found to oxidize the methionine residue, but notably, this oxidative modification occurs only in the aggregated HTT but not in the soluble state.	Methionine	72-82	huntingtin	Homo sapiens	163-166	
22891249-6	2012	Furthermore, the methionine oxidation creates additional interactions among HTT aggregates and alters overall morphologies of the aggregates.	Methionine	17-27	huntingtin	Homo sapiens	76-79